WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CERULEAN was filed as Word mark on 06/25/2013 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1169414 |
| Countries | 
|
| Base trademark |
No. ,
September 13, 2024
|
| Application date | June 25, 2013 |
| Expiration date | June 25, 2023 |
Trademark owner
840 Memorial Drive, 5th Floor
Cambridge, MA 02139
US
Cambridge, MA 02139
US
Trademark representatives
4 Times Square,
New York NY 10036
US
goods and services
01
Diagnostic and prognostic preparations for clinical or
medical laboratory use; diagnostic and prognostic reagents
for identifying a disease or disorder and/or the progression
of a disease or disorder
05
Pharmaceutical preparations for use in the treatment of
oncological diseases or disorders, including malignant
cancers or neoplasms; pharmaceutical preparations for use in
chemotherapy; pharmaceutical preparations for use in the
treatment of oncological diseases or disorders, including
malignant cancers or neoplasms; pharmaceutical preparations
for use in chemotherapy; pharmaceutical preparations for use
in the treatment of oncological diseases or disorders,
including malignant cancers or neoplasms, all containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient; pharmaceutical
preparations for use in chemotherapy, containing nanometer
size compounds which facilitate targeting or delivery of the
active ingredient; pharmaceutical preparations for use in
the diagnosis, prognosis or prevention of oncological
diseases or disorders, including malignant cancers or
neoplasms; pharmaceutical preparations for use in the
diagnosis, prognosis, prevention or treatment of oncological
diseases or disorders, including pre-cancerous diseases or
disorders and benign cancers or neoplasms, inflammation and
inflammatory diseases or disorders, and cardiovascular
diseases or disorders; pharmaceutical preparations for use
in modulating angiogenesis; pharmaceutical preparations for
use in the diagnosis, prognosis and prevention of
oncological diseases or disorders, including malignant
cancers or neoplasms, all containing nanometer size
compounds which facilitate targeting or delivery of the
active ingredient; pharmaceutical preparations for use in
the diagnosis, prognosis, prevention or treatment of
oncological diseases or disorders, including pre-cancerous
diseases or disorders and benign cancers or neoplasms,
inflammation and inflammatory diseases or disorders, and
cardiovascular diseases or disorders, all containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient; pharmaceutical
preparations for use in modulating angiogenesis, containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient
42
Medical and scientific research services, namely, research,
development, analytical, formulation, and product
development services in the pharmaceutical field
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 9, 2019 | 2019/27 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| October 14, 2016 | 2017/26 Gaz | US | RAW: Partial Ceasing Effect |
| October 29, 2014 | 2014/47 Gaz | CN | Rejection |
| June 25, 2013 | 2013/29 Gaz | US | Registration |
ID: 141169414